Pharmaron’s 9th Symposium: Synthetic and Medicinal Chemistry
Capabilities
On September 21, 2019, Pharmaron is holding its ninth annual Synthetic and Medicinal Chemistry symposium. The symposium is an opportunity for our scientists and partners to learn from world-class researchers from both industry and academia. The esteemed group of presenters will discuss the latest synthetic and medicinal chemistry advancements. This symposium aims to spark innovation, the foundation of Pharmaron’s continued success.
Symposium Speakers:
- Dr. Kevin Campos, MSD, USA
Innovations in Synthetic Chemistry at MSD: Striving for the Ideal Commercial Manufacturing Process - Dr. Werngard Czechtizky, AstraZeneca, Sweden
Leveraging New Modalities for Respiratory: The Exciting Chemical Space between Small Molecules & Antibodies - Prof. Francois Diederich, ETH Zurich, Switzerland
Molecular Recognition in Chemical and Biological Systems: Chemical Models and Biostructural Investigations - Dr. Michael Hahn, Bayer AG, Germany
Discovery of a Novel Oral NO- and Heme-Independent sGC Activator BAY 1101042 - Dr. Bayard R. Huck, Merck KGaA, Germany
It’s a Small-Molecule World: Medicinal Chemistry Challenges and Opportunities for the Next Decade - Prof. Guosheng Liu, Shanghai Institute of Organic Chemistry, China
Copper-Catalyzed Radical Relay for Asymmetric C-H Functionalization - Prof. David MacMillan, Princeton University, USA
New Photoredox Reactions for Medicinal Chemistry and Biological - Dr. Jan Willem Thuring, Janssen Pharmaceutica Research & Development, Belgium
Discovery of JNJ-64619178 as a Potent and Selective PRMT5 Inhibitor for the Treatment of Lung and Hematologic Cancers
Learn more about Pharmaron’s symposiums and forums
